Epidemiological characteristics of patients infected with SARS-CoV-2 in Itapúa, Paraguay, from August 2020 to January 2021
DOI:
https://doi.org/10.70833/rseisa16item306Keywords:
Paraguay, Coronavirus, Covid-19, EpidemiologyAbstract
The pandemic caused by the SARS-CoV-2 virus, the triggering factor for the Covid-19 disease, starts in Wuhan, China. In Paraguay, the first case of Covid-19 infection was detected on March 7th, 2020. Since then, the number of cases raised month by month until the virus was spread around the entire country. The objective of this study was to evaluate the epidemiological characteristics of patients with SARS-CoV-2 virus in samples from the Molecular Biology Laboratory of the Regional Hospital of Encarnación, Itapúa-Paraguay from August 2020 until January 2021, using epidemiological data from the General Directorate of Health Surveillance. A descriptive, prospective, cross-sectional study was carried out, 11,400 samples identified by the qRT-PCR technique were processed, of which 2,193 were positive, with a higher incidence in the months of October 2020 and January 2021 in Itapúa. Most of the cases corresponded to the female sex (54.17%). The 85,13% of the patients exhibited symptoms. The months that registered peak cases were October and January. The age range with the highest percentage of infections was from 21 to 30 years old. The identified most frequent symptoms were headaches, nasal congestion, cough, and sore throat. The median of Ct values decreased in January, and the average values for E and RdRp 2 genes were lower than ORF1ab and N genes. On the whole, epidemiology characteristics of Covid-19 positive patients were described in the analyzed period
Downloads
References
Barrientos, T., Alpuche, C., Lazcano, E., Pérez, C., & Rivera, J. (2020). La Salud Pública En La Primera Ola: Una Agenda Para La Cooperación Ante Covid-19. Salud Publica de Mexico 62(5),598–606. doi: 10.21149/11606.
de Carvalho, A., Scavuzzi, V., Cezarotti, M., Cavalcanti P., Silveira, R., Timbó, F., Matos, T., et al. (2020). Epidemiology, Diagnosis, Treatment, and Future Perspectives Concerning SARS-COV-2: A Review Article [Epidemiología, Diagnóstico, Tratamiento y futuras perspectivas concernientes al SARS-COV-2: artículo de revisión]. Revista Da Associacao Medica Brasileira 66(3), 370–74. doi: 10.1590/1806-9282.66.3.370.
Dahdouh, E., F.; Lazaro, M.; Romero, J.; Mingorance, C., & Garcia, J. (2021). Ct Values from SARS-CoV-2 Diagnostic PCR Assays Should Not Be Used as Direct Estimates of Viral Load [valores de Ct de los ensayos de PCR de diagnóstico de SARS-CoV-2 no deben usarse como estimaciones directas de la carga viral]. Journal of Infection 82(3), 414–51.
Guan, W., Zheng, N., Wen, L., Chun, O., Jian, H., Hong, L., Chun, L., et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China [Características clínicas de la enfermedad del Coronavirus 2019 en China]. New England Journal of Medicine 382(18),1708–20. doi: 10.1056/nejmoa2002032.
Johns Hopkins University and Medicine. (2020). Coronavirus Resource Center. Retrieved (https://coronavirus.jhu.edu/map.html).
Kelleni, T. (2021). SARS CoV-2 Viral Load Might Not Be the Right Predictor of COVID-19 Mortality. [La carga viral del SARS CoV-2 podría no ser el predictor adecuado de la mortalidad por COVID-19] Journal of Infection 82(2):e35. doi: 10.1016/j.jinf.2020.08.018.
Kidd, M., Richter, A., Best, A., Cumley, N., Mirza, J., Percival, B., Megram, O. et al. (2021). S-Variant SARS-CoV-2 Lineage B1.1.7 Is Associated with Significantly Higher Viral Loads in Samples Tested by ThermoFisher TaqPath RT-QPCR. [El linaje B1.1.7 del SARS-CoV-2 variante S se asocia con cargas virales significativamente más altas en muestras analizadas por ThermoFisher TaqPath RT-QPCR] The Journal of Infectiuos Diseases 1–16.
de la Calle, C., Lalueza, A., Mancheño ,M., de la Calle, G., Lora, J., Arrieta, E., García, A. et al. (2021). Impact of Viral Load at Admission on the Development of Respiratory Failure in Hospitalized Patients with SARS-CoV-2 Infection [Impacto de la carga viral al ingreso en el desarrollo de insuficiencia respiratoria en pacientes hospitalizados con infección por SARS-CoV-2]. European Journal of Clinical Microbiology and Infectious Diseases (Il). doi: 10.1007/s10096-020-04150-w.
Millán, J., Rodriguez, A., Camacho, G., & Mendoza, H. (2021). A New Emerging Zoonotic Virus of Concern : The 2019 Novel Coronavirus ( SARS CoV-2 ) [Un nuevo virus zoonótico emergente preocupante: el nuevo coronavirus de 2019]. Infectio 24(3), 187–92.
Ministerio de Salud Pública y Bienestar Social. (2020a). Pruebas Para La Detección de Antígenos de SARS-COV-2. Retrieved February 9, 2021 (https://www.mspbs.gov.py/dependencias/portal/adjunto/06462e-DetecciondeAntigenos.pdf).
Ministerio de Salud Pública y Bienestar Social. (2020b). REPORTE PARAGUAY MSPBS COVID19 (https://www.mspbs.gov.py/dependencias/portal/adjunto/06470e-reportes.pdf).
Ministerio de Salud Pública y Bienestar Social. (2021). Reporte Coronavirus/COVID-19 En Paraguay Del 31 de Enero Del 2021. Retrieved April 20, 2021 (https://www.mspbs.gov.py/dependencias/portal/adjunto/a1685e-31deEnero.pdf).
OPS/OMS. (2020). Actualización Epidemiológica Nuevo Coronavirus (COVID-19). Organización Panamericana de La Salud 1–9.
Rearte, A., Baldani, A., Barcena, P., Domínguez, C., Laurora, M., Pesce, M., Rojas, M. et al (2020). Características Epidemiológicas de Los Primeros 116 974 Casos de Covid-19 En Argentina, 2020. Revista Argentina de Salud Pública 12:1–9.
RENAVE. (2021). Informe No 60. Situación de COVID-19 En España. Casos Diagnosticados a Partir 10 de Mayo.
La Scola, B., Le Bideau, M., Andreani, J., Grimaldier, C., Colson, P., Gautret, P.,& Raoult, D. (2020). Viral RNA Load as Determined by Cell Culture as a Management Tool for Discharge of SARS-CoV-2 Patients from Infectious Disease Wards [Carga de ARN viral determinada por cultivo celular como herramienta de gestión para el alta de pacientes con SARS-CoV-2 de salas de enfermedades infecciosas]. European Journal of Clinical Microbiology and Infectious Diseases 39(6):1059–61. doi: 10.1007/s10096-020-03913-9.
Simian M, & Cifuentes, M. (2020). Caracterización Epidemiológica de Pacientes Con Covid-19 En El Hospital Clínico Universidad de Chile. Rev. Hosp. Clin. Univ. Chile 31(2), 103–8.
Team, The Novel Coronavirus Pneumonia Emergency Response Epidemiology. (2021). The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) [Las características epidemiológicas de un brote de nuevas enfermedades por coronavirus de 2019]China CDC 2:3.
Walsh, A., Jordan, K., Clyne, B., Rohde, D., Drummond, L., Byrne, P., Ahern, S. et al. (2020). SARS-CoV-2 Detection, Viral Load and Infectivity over the Course of an Infection [Detección de SARS-CoV-2, carga viral e infectividad durante el curso de una infección]. Journal of Infection 81(3), 357–71. doi: 10.1016/j.jinf.2020.06.067.
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, J. et al (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. [Un nuevo coronavirus de pacientes con neumonía en China, 2019]. New England Journal of Medicine 382(8):727–33. doi: 10.1056/nejmoa2001017.
Downloads
Published
How to Cite
License
Copyright (c) 2022 Mónica María González, Diana Paola Dressler Sanabria, Liliana Noelia Talavera Stéfani, Sandra Virginia Caballero Gómez, María José Arrúa Acosta
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution License CC-BY
You are free to:
Share — copy and redistribute the material in any medium or format.
Adapt — remix, transform, and build upon the material for any purpose, including commercially.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if any changes have been made. You may do so in any reasonable way, but not in any way that suggests that you or your use is endorsed by the Licensor.
